Advertisement
Screener

Enumeral Biomedical Holdings, Inc. Research and Development Expense

Enumeral Biomedical Holdings, Inc. Research and Development Expense

Enumeral Biomedical Holdings, Inc. reported Research and Development Expense of $90.82 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-14.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2017-11-14

  • Enumeral Biomedical Holdings, Inc. research and development expense for the quarter ending 2017-09-30 was $90.82K, a 91.15% decline year-over-year.
  • Enumeral Biomedical Holdings, Inc. research and development expense for the quarter ending 2017-06-30 was $883.34K, a 28.81% decline year-over-year.
  • Enumeral Biomedical Holdings, Inc. research and development expense for the quarter ending 2017-03-31 was $1.15M, a 22.04% decline year-over-year.
  • Enumeral Biomedical Holdings, Inc. research and development expense for the quarter ending 2016-12-31 was $1.13M, a 32.05% decline year-over-year.
  • Enumeral Biomedical Holdings, Inc. research and development expense for fiscal 2016 was $4.87M, a 25.08% decline from fiscal 2015.
  • Enumeral Biomedical Holdings, Inc. research and development expense for fiscal 2015 was $6.49M, a 81.61% increase from fiscal 2014.
  • Enumeral Biomedical Holdings, Inc. research and development expense for fiscal 2014 was $3.58M, a 50.91% increase from fiscal 2013.
  • Enumeral Biomedical Holdings, Inc. research and development expense for fiscal 2013 was $2.37M.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 month
2017-09-30$90.82K
10-Q · filed 2017-11-14
$974.16K
derived: sum of 2 quarters · filed 2017-11-14
$2.12M
10-Q · filed 2017-11-14
$3.25M
derived: sum of 4 quarters · filed 2017-11-14
2017-06-30$883.34K
10-Q · filed 2017-08-14
$2.03M
10-Q · filed 2017-08-14
$3.16M
derived: sum of 3 quarters · filed 2017-08-14
$4.18M
derived: sum of 4 quarters · filed 2017-11-14
2017-03-31$1.15M
10-Q · filed 2017-05-22
$2.27M
derived: sum of 2 quarters · filed 2017-05-22
$3.30M
derived: sum of 3 quarters · filed 2017-11-14
$4.54M
derived: sum of 4 quarters · filed 2017-11-14
2016-12-31$1.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-28
$2.15M
derived: sum of 2 quarters · filed 2017-11-14
$3.40M
derived: sum of 3 quarters · filed 2017-11-14
$4.87M
10-K · filed 2017-03-28
2016-09-30$1.03M
10-Q · filed 2017-11-14
$2.27M
derived: sum of 2 quarters · filed 2017-11-14
$3.74M
10-Q · filed 2017-11-14
$5.40M
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30$1.24M
10-Q · filed 2017-08-14
$2.71M
10-Q · filed 2017-08-14
$4.37M
derived: sum of 3 quarters · filed 2017-08-14
$6.17M
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31$1.47M
10-Q · filed 2017-05-22
$3.13M
derived: sum of 2 quarters · filed 2017-05-22
$4.93M
derived: sum of 3 quarters · filed 2017-05-22
$6.73M
derived: sum of 4 quarters · filed 2017-05-22
2015-12-31$1.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-28
$3.46M
derived: sum of 2 quarters · filed 2017-03-28
$5.26M
derived: sum of 3 quarters · filed 2017-03-28
$6.49M
10-K · filed 2017-03-28
2015-09-30$1.80M
10-Q · filed 2016-11-10
$3.60M
derived: sum of 2 quarters · filed 2016-11-10
$4.83M
10-Q · filed 2016-11-10
$5.87M
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30$1.81M
10-Q · filed 2016-08-12
$3.04M
10-Q · filed 2016-08-12
$4.08M
derived: sum of 3 quarters · filed 2016-08-12
$5.13M
derived: sum of 4 quarters · filed 2016-08-12
2015-03-31$1.23M
10-Q · filed 2016-05-13
$2.27M
derived: sum of 2 quarters · filed 2016-05-13
$3.33M
derived: sum of 3 quarters · filed 2016-05-13
$4.12M
derived: sum of 4 quarters · filed 2016-05-13
2014-12-31$1.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
$2.10M
derived: sum of 2 quarters · filed 2016-03-30
$2.89M
derived: sum of 3 quarters · filed 2016-03-30
$3.58M
10-K · filed 2016-03-30
2014-09-30$1.06M
10-Q · filed 2015-11-10
$1.85M
derived: sum of 2 quarters · filed 2015-11-10
$2.54M
10-Q · filed 2015-11-10
$3.15M
derived: sum of 4 quarters · filed 2015-11-10
2014-06-30$791.11K
10-Q · filed 2015-08-12
$1.48M
10-Q · filed 2015-08-12
$2.10M
derived: sum of 3 quarters · filed 2015-08-12
$2.68M
derived: sum of 4 quarters · filed 2015-08-12
2014-03-31$685.41K
10-Q · filed 2015-05-15
$1.31M
derived: sum of 2 quarters · filed 2015-05-15
$1.89M
derived: sum of 3 quarters · filed 2015-05-15
2013-12-31$619.64K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19
$1.20M
derived: sum of 2 quarters · filed 2015-03-19
$2.37M
10-K · filed 2015-03-19
2013-09-30$583.37K
10-Q · filed 2014-11-14
$1.75M
10-Q · filed 2014-11-14